Support and Resources | IMFINZI® (durvalumab) & IMJUDO® (tremelimumab-actl) for HCPs is a high-quality image in the Mayo collection, available at 1600 × 1300 pixels resolution — ideal for both digital and print use.
Learn about common Imfinzi side effects and potential immunotherapy risks. Understand symptoms, management tips, and when to contact your doctor for care.
Image Details
| Title | Support and Resources | IMFINZI® (durvalumab) & IMJUDO® (tremelimumab-actl) for HCPs |
|---|---|
| Dimensions | 1600 × 1300 px |
| Category | Mayo |
| Published | June 29, 2025 |
| Author | Zeus |
| Downloads | 1,806 |
| Views | 573 |
Frequently Asked Questions
This image has a resolution of 1600 × 1300 pixels. It is suitable for high-quality printing, digital presentations, and web use without losing clarity.
This image is part of the Mayo collection. You can browse more images in this category to find similar content.
Click the Download button above the image to save it directly to your device. The image is provided in its original resolution of 1600 × 1300 px.
Yes! Scroll down to the More Images section below to explore related Mayo images. You can also visit the full article for more context and a complete image gallery.
Read full article: Imfinzi Side Effects